Surgery is the standard of care for T1bN0M0 esophageal squamous cell carcinoma (ESCC), while chemoradiotherapy (CRT) is a treatment option. This trial aimed to investigate the non-inferiority of CRT relative to surgery for T1bN0M0 ESCC.
Surgery is the standard of care for T1bN0M0 esophageal squamous cell carcinoma (ESCC), while chemoradiotherapy (CRT) is a treatment option. This trial aimed to investigate the non-inferiority of CRT relative to surgery for T1bN0M0 ESCC.